STOCK TITAN

Whetstone reports 5.3% stake in Health Catalyst

Health Catalyst, Inc. received an updated ownership report showing that Whetstone Capital Advisors, LLC and David Atterbury together beneficially own 3,750,377 shares of its common stock.

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Health Catalyst, Inc. received an updated ownership report showing that Whetstone Capital Advisors, LLC and David Atterbury together beneficially own 3,750,377 shares of its common stock. This stake represents 5.3% of the company’s outstanding common shares as of the reporting date.

The filing states that the reporting persons share both voting and dispositive power over all of these shares and have no sole voting or dispositive authority. They also certify that the shares were not acquired for the purpose of changing or influencing control of Health Catalyst.

Positive

  • None.

Negative

  • None.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What ownership stake in HCAT does Whetstone Capital report?

Whetstone Capital Advisors, LLC and David Atterbury report beneficial ownership of 3,750,377 Health Catalyst common shares, representing 5.3% of the class.

Who are the reporting persons in this Health Catalyst (HCAT) Schedule 13G/A?

The reporting persons are Whetstone Capital Advisors, LLC and David Atterbury, who filed jointly as the beneficial owners of the shares.

Does Whetstone have sole or shared voting power over HCAT shares?

The filing shows 0 shares with sole voting power and 3,750,377 shares with shared voting power and shared dispositive power.

What class of Health Catalyst (HCAT) securities is covered in this filing?

The filing covers common stock of Health Catalyst, Inc., with a par value of $0.001 per share and CUSIP 42225T107.

Is Whetstone’s HCAT position reported as passive or control-seeking?

The certification states the securities were not acquired and are not held for the purpose of changing or influencing control of Health Catalyst.

What is the relevant date for this HCAT Schedule 13G/A ownership report?

The date of the event requiring the filing is listed as 12/31/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Whetstone Capital Advisors, LLC
Signature:/s/ David Atterbury
Name/Title:Manager
Date:01/14/2026
David Atterbury
Signature:/s/ David Atterbury
Name/Title:CCO/President
Date:01/14/2026

Keep reading